Literature DB >> 30803232

Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy.

Wei Xie, Wei-Wei Deng, Minghui Zan, Lang Rao, Guang-Tao Yu, Dao-Ming Zhu, Wen-Tao Wu, Bei Chen, Li-Wei Ji, Liben Chen1, Kan Liu2,3, Shi-Shang Guo, Hui-Ming Huang, Wen-Feng Zhang, Xingzhong Zhao, Yufeng Yuan4, Wenfei Dong5, Zhi-Jun Sun, Wei Liu4.   

Abstract

Although anti-PD-1 immunotherapy is widely used to treat melanoma, its efficacy still has to be improved. In this work, we present a therapeutic method that combines immunotherapy and starvation therapy to achieve better antitumor efficacy. We designed the CMSN-GOx method, in which mesoporous silica nanoparticles (MSN) are loaded with glucose oxidase (GOx) and then encapsulate the surfaces of cancer cell membranes to realize starvation therapy. By functionalizing the MSN's biomimetic surfaces, we can synthesize nanoparticles that can escape the host immune system and homologous target. These attributes enable the nanoparticles to have improved cancer targeting ability and enrichment in tumor tissues. Our synthetic CMSN-GOx complex can ablate tumors and induce dendritic cell maturity to stimulate an antitumor immune response. We performed an in vivo analysis of these nanoparticles and determined that our combined therapy CMSN-GOx plus PD-1 exhibits a better antitumor therapeutic effect than therapies using CMSN-GOx or PD-1 alone. Additionally, we used the positron emission tomography imaging to measuring the level of glucose metabolism in tumor tissues, for which we investigate the effect with the cancer therapy in vivo.

Entities:  

Keywords:  cancer cell membrane; immunotherapy; positron emission tomography; starvation therapy

Year:  2019        PMID: 30803232     DOI: 10.1021/acsnano.8b03788

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  36 in total

1.  Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.

Authors:  Flavia Fontana; Raquél Bartolo; Hélder A Santos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma.

Authors:  Xi Hu; Fan Xia; Jiyoung Lee; Fangyuan Li; Xiaoyang Lu; Xiaozhen Zhuo; Guangjun Nie; Daishun Ling
Journal:  Adv Sci (Weinh)       Date:  2021-02-12       Impact factor: 16.806

3.  Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy.

Authors:  Wei Pei; Ling Cai; Xing Gong; Li Zhang; Jiarong Zhang; Ping Zhu; Huijun Jiang; Chao Wang; Shoulin Wang; Jin Chen
Journal:  Mater Today Bio       Date:  2022-05-04

4.  Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity.

Authors:  Qichao Yang; Xianbin Ma; Yao Xiao; Tian Zhang; Leilei Yang; Shaochen Yang; Mengyun Liang; Shuo Wang; Zhizhong Wu; Zhigang Xu; Zhijun Sun
Journal:  Acta Pharm Sin B       Date:  2022-02-26       Impact factor: 14.903

Review 5.  Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.

Authors:  Ranjith Kumar Kankala; Ya-Hui Han; Hong-Ying Xia; Shi-Bin Wang; Ai-Zheng Chen
Journal:  J Nanobiotechnology       Date:  2022-03-12       Impact factor: 10.435

Review 6.  Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?

Authors:  Shiyi Zuo; Jiaxuan Song; Jingxuan Zhang; Zhonggui He; Bingjun Sun; Jin Sun
Journal:  Theranostics       Date:  2021-06-01       Impact factor: 11.556

7.  Enhanced Tumor Targeting and Radiotherapy by Quercetin Loaded Biomimetic Nanoparticles.

Authors:  Chunyu Huang; Tongkai Chen; Daoming Zhu; Qinqin Huang
Journal:  Front Chem       Date:  2020-03-31       Impact factor: 5.221

Review 8.  Advances in nanomedicine for cancer starvation therapy.

Authors:  Shuangjiang Yu; Zhaowei Chen; Xuan Zeng; Xuesi Chen; Zhen Gu
Journal:  Theranostics       Date:  2019-10-17       Impact factor: 11.556

Review 9.  Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma.

Authors:  Vera Petrova; Ihor Arkhypov; Rebekka Weber; Christopher Groth; Peter Altevogt; Jochen Utikal; Viktor Umansky
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

Review 10.  Surface-functionalised hybrid nanoparticles for targeted treatment of cancer.

Authors:  Hasnat Tariq; Syed Ali Imran Bokhari
Journal:  IET Nanobiotechnol       Date:  2020-09       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.